Cytogenetics and cell surface marker analysis in chronic myelocytic leukemia. II. Implications for patient management

Chronic myelocytic leukemia (CML) is a model system for the study of many aspects of malignant disease. One aspect that correlates with decreasing therapeutic response is tumor progression. This progression is often accompanied by clonal evolution. In those cases where aggressive therapy does not pr...

Ausführliche Beschreibung